Disc Medicine, Inc. Operating Income Loss

• Disc Medicine, Inc. showed a decrease of -81.9% in Operating Income Loss from 2024 to 2025.
• This data is from Disc Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Disc Medicine, Inc.'s Operating Income Loss has declined by 593.4%.
• Historical annual values: Fiscal year 2025: -$236.02 million | Fiscal year 2024: -$129.72 million | Fiscal year 2023: -$91.13 million | Fiscal year 2022: -$47.48 million | Fiscal year 2021: -$30.93 million | Fiscal year 2020: -$34.04 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026